within Pharmacolibrary.Drugs.J_AntiinfectivesForSystemicUse.J05A_DirectActingAntivirals.J05AP01_Ribavirin;

model Ribavirin
  extends Pharmacolibrary.Drugs.ATC.J.J05AP01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>J05AP01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Ribavirin is a synthetic nucleoside analog with broad-spectrum antiviral activity. It is primarily used for the treatment of hepatitis C in combination with other drugs and for severe respiratory syncytial virus (RSV) infections in certain populations. Ribavirin is approved for use in combination therapy for hepatitis C virus (HCV) infection and is also used off-label for other viral infections.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported in healthy adult males after single oral dose.</p><h4>References</h4><ol><li><p>K Gupta, S, et al., &amp; Glue, P (2014). Exploring the influence of renal dysfunction on the pharmacokinetics of ribavirin after oral and intravenous dosing. <i>Drug discoveries &amp; therapeutics</i> 8(2) 89–95. DOI:<a href=\"https://doi.org/10.5582/ddt.8.89\">10.5582/ddt.8.89</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/24815584/\">https://pubmed.ncbi.nlm.nih.gov/24815584</a></p></li><li><p>Glue, P (1999). The clinical pharmacology of ribavirin. <i>Seminars in liver disease</i> 19 Suppl 1 17–24. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/10349689/\">https://pubmed.ncbi.nlm.nih.gov/10349689</a></p></li><li><p>Vispo, E, et al., &amp; Soriano, V (2013). Pharmacokinetics of new oral hepatitis C antiviral drugs. <i>Expert opinion on drug metabolism &amp; toxicology</i> 9(1) 5–16. DOI:<a href=\"https://doi.org/10.1517/17425255.2013.729577\">10.1517/17425255.2013.729577</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/23094639/\">https://pubmed.ncbi.nlm.nih.gov/23094639</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Ribavirin;
